32
Views
0
CrossRef citations to date
0
Altmetric
Theme: Cardiovascular Disease - Review

Valvular Heart Disease in Older Adults: Evolving Technology to Meet the Needs of Aging Patients

, &
Pages 205-215 | Published online: 04 Apr 2013

References

  • d‘Arcy JL , PrendergastBD, ChambersJB, RaySG, BridgewaterB. Valvular heart disease: the next cardiac epidemic. Heart97(2), 91–93(2011).
  • Nkomo VT , GardinJM, SkeltonTN, GottdienerJS, ScottCG, Enriquez-SaranoM. Burden of valvular heart diseases: a population-based study. Lancet368(9540), 1005–1011(2006).
  • Iung B , BaronG, ButchartEGet al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur. Heart J. 24(13), 1231–1243(2003).
  • Ross J Jr, Braunwald E. Aortic stenosis. Circulation38(Suppl. 1), S61–S67 (1968).
  • Rossebo AB , PedersenTR, BomanKet al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359(13), 1343–1356(2008).
  • Chan KL , TeoK, DumesnilJG, NiA, TamJ. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation121(2), 306–314(2010).
  • Cowell SJ , NewbyDE, PrescottRJet al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352(23), 2389–2397(2005).
  • Pellikka PA , SaranoME, NishimuraRAet al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111(24), 3290–3295(2005).
  • Schwarz F , BaumannP, MantheyJet al. The effect of aortic valve replacement on survival. Circulation 66(5), 1105–1110(1982).
  • Bonow RO , CarabelloBA, ChatterjeeKet al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118(15), e523–e661 (2008).
  • Vahanian A , AlfieriO, AndreottiFet al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 33(19), 2451–2496(2012).
  • Rosenhek R , ZilberszacR, SchemperMet al. Natural history of very severe aortic stenosis. Circulation 121(1), 151–156(2010).
  • American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: executive summary. Circulation114(5), 450–527(2006).
  • Brown JM , O‘BrienSM, WuC, SikoraJAH, GriffithBP, GammieJS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg.137(1), 82–90(2009).
  • Goodney PP , O‘ConnorGT, WennbergDE, BirkmeyerJD. Do hospitals with low mortality rates in coronary artery bypass also perform well in valve replacement? Ann. Thorac. Surg.76(4), 1131–1136; discussion 1136–1137 (2003).
  • Langanay T , FlecherE, FouquetOet al. Aortic valve replacement in the elderly: the real life. Ann. Thorac. Surg. 93(1), 70–77; discussion 77–78 (2012).
  • Bakaeen FG , ChuD, HuhJ, CarabelloBA. Is an age of 80 years or greater an important predictor of short-term outcomes of isolated aortic valve replacement in veterans? Ann. Thorac. Surg.90(3), 769–774(2010).
  • Varadarajan P , KapoorN, BansalRC, PaiRG. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or =80 years. Eur. J. Cardiothorac. Surg.30(5), 722–727(2006).
  • Asimakopoulos G , EdwardsMB, TaylorKM. Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation96(10), 3403–3408(1997).
  • Florath I , AlbertA, RosendahlU, AlexanderT, EnnkerIC, EnnkerJ. Mid term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves. Heart91(8), 1023–1029(2005).
  • Maillet JM , SommeD, HennelE, LessanaA, Saint-JeanO, BrodatyD. Frailty after aortic valve replacement (AVR) in octogenarians. Arch. Gerontol. Geriatr.48(3), 391–396(2009).
  • Bouma BJ , van Den Brink RB, van Der Meulen JH et al. To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart82(2), 143–148(1999).
  • Bouma BJ , Van Der Meulen JH, Van Den Brink RB et al. Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in The Netherlands. Heart85(2), 196–201(2001).
  • Freed BH , SugengL, FurlongKet al. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am. J. Cardiol. 105(9), 1339–1342(2010).
  • Bach DS , SiaoD, GirardSE, DuvernoyC, McCallisterBD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ. Cardiovasc. Qual. Outcomes2(6), 533–539(2009).
  • Iung B , CachierA, BaronGet al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26(24), 2714–2720(2005).
  • Dewey TM , BrownDL, DasTSet al. High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann. Thorac. Surg. 86(5), 1450–1456; discussion 1456–1457 (2008).
  • Wenaweser P , PilgrimT, KadnerAet al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J. Am. Coll. Cardiol. 58(21), 2151–2162(2011).
  • Fried LP , TangenCM, WalstonJet al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56(3), M146–M156 (2001).
  • Purser JL , KuchibhatlaMN, FillenbaumGG, HardingT, PetersonED, AlexanderKP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J. Am. Geriatr. Soc.54(11), 1674–1681(2006).
  • Ekerstad N , SwahnE, JanzonMet al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction/clinical perspective. Circulation 124(22), 2397–2404(2011).
  • Makary MA , SegevDL, PronovostPJet al. Frailty as a predictor of surgical outcomes in older patients. J. Am. Coll. Surg. 210(6), 901–908(2010).
  • Afilalo J , EisenbergMJ, MorinJFet al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J. Am. Coll. Cardiol. 56(20), 1668–1676(2010).
  • Sundermann S , DademaschA, PraetoriusJet al. Comprehensive assessment of frailty for elderly high-risk patients undergoing cardiac surgery. Eur. J. Cardiothorac. Surg. 39(1), 33–37(2010).
  • Afilalo J , MottilloS, EisenbergMJet al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ. Cardiovasc. Qual. Outcomes 5(2), 222–228(2012).
  • Fried LP , HadleyEC, WalstonJDet al. From bedside to bench: research agenda for frailty. Sci. Aging Knowledge Environ. 2005(31), pe24 (2005).
  • Gallucci M , OngaroF, AmiciGP, ReginiC. Frailty, disability and survival in the elderly over the age of seventy: evidence from ‘The Treviso Longeva (TRELONG) Study’. Arch. Gerontol. Geriatr.48(3), 281–283(2009).
  • Green P , WoglomAE, GenereuxPet al. Gait speed and dependence in activities of daily living in older adults with severe aortic stenosis. Clin. Cardiol. 35(5), 307–314(2012).
  • Ewe SH , Ajmone Marsan N, Pepi M et al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am. Heart J.160(6), 1113–1120(2010).
  • Green P , WoglomAE, GenereuxPet al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc. Interv. 5(9), 974–981(2012).
  • Schoenenberger AW , StorteckyS, NeumannSet al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur. Heart J. 34(9), 684–692(2013).
  • Cribier A , EltchaninoffH, BashAet al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006–3008(2002).
  • Genereux P , HeadSJ, WoodDAet al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur. Heart J. 33(19), 2388–2398(2012).
  • Leon MB , SmithCR, MackMet al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607(2010).
  • Smith CR , LeonMB, MackMJet al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187–2198(2011).
  • Makkar RR , FontanaGP, JilaihawiHet al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366, 1696–1704(2012).
  • Kodali SK , WilliamsMR, SmithCRet al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366, 1686–1695(2012).
  • Reynolds MR , MagnusonEA, WangKet al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J. Am. Coll. Cardiol. 60(6), 548–558(2012).
  • Reynolds MR , MagnusonEA, LeiYet al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 124(18), 1964–1972(2011).
  • Spertus J , PetersonE, ConardMWet al. Monitoring clinical changes in patients with heart failure: a comparison of methods. Am. Heart J. 150(4), 707–715(2005).
  • Detaint D , SundtTM, NkomoVTet al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 114(4), 265–272(2006).
  • Chikwe J , GoldstoneAB, PassageJet al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur. Heart J. 32(5), 618–626(2011).
  • Digregorio V , ZehrKJ, OrszulakTAet al. Results of mitral surgery in octogenarians with isolated nonrheumatic mitral regurgitation. Ann. Thorac. Surg. 78(3), 807–813; discussion 813–814 (2004).
  • Nloga J , HénaineR, VergnatMet al. Mitral valve surgery in octogenarians: should we fight for repair? A survival and quality-of-life assessment. Eur. J. Cardiothorac. Surg. 39(6), 875–880(2011).
  • Enriquez-Sarano M , AkinsCW, VahanianA. Mitral regurgitation. Lancet373(9672), 1382–1394(2009).
  • Trichon BH , FelkerGM, ShawLK, CabellCH, O‘ConnorCM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am. J. Cardiol.91(5), 538–543(2003).
  • Grossi EA , CrookeGA, DigiorgiPLet al. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation 114(Suppl. 1), I573–I576 (2006).
  • Bursi F , Enriquez-SaranoM, NkomoVTet al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111(3), 295–301(2005).
  • Stevenson LW , BellilD, Grover-MckayMet al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 60(8), 654–658(1987).
  • Hamilton MA , StevensonLW, ChildJS, MoriguchiJD, WaldenJ, WooM. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. Am. J. Cardiol.67(4), 259–263(1991).
  • Levine AB , MullerC, LevineTB. Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling. Am. J. Cardiol.82(10), 1299–1301, A10 (1998).
  • Lowes BD , GillEA, AbrahamWTet al. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am. J. Cardiol. 83(8), 1201–1205(1999).
  • Capomolla S , FeboO, GnemmiMet al. β-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am. Heart J. 139(4), 596–608(2000).
  • St John Sutton MG , PlappertT, AbrahamWTet al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107(15), 1985–1990(2003).
  • Mirabel M , IungB, BaronGet al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur. Heart J. 28(11), 1358–1365(2007).
  • Whitlow PL , FeldmanT, PedersenWRet al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J. Am. Coll. Cardiol. 59(2), 130–139(2012).
  • Webb JG , WoodDA. Current status of transcatheter aortic valve replacement. J. Am. Coll. Cardiol.60(6), 483–492(2012).
  • Feldman T , CilingirogluM. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J. Am. Coll. Cardiol.57(5), 529–537(2011).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.